IRIS Institutional Research Information System - OPENBS Open Archive UniBS

RUSSO, DOMENICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.031
AS - Asia 12.764
EU - Europa 10.165
SA - Sud America 3.176
AF - Africa 300
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 27
Totale 49.501
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.670
SG - Singapore 4.449
CN - Cina 4.099
UA - Ucraina 2.768
BR - Brasile 2.690
HK - Hong Kong 1.735
DE - Germania 1.560
IT - Italia 1.315
PL - Polonia 1.082
VN - Vietnam 814
FI - Finlandia 798
TR - Turchia 571
RU - Federazione Russa 554
GB - Regno Unito 553
IE - Irlanda 493
IN - India 343
SE - Svezia 304
FR - Francia 268
AR - Argentina 195
CA - Canada 166
BD - Bangladesh 162
MX - Messico 116
ZA - Sudafrica 106
ID - Indonesia 92
IQ - Iraq 85
EC - Ecuador 81
CZ - Repubblica Ceca 78
JP - Giappone 70
AT - Austria 64
NL - Olanda 61
ES - Italia 60
BE - Belgio 57
CO - Colombia 57
UZ - Uzbekistan 45
VE - Venezuela 42
SA - Arabia Saudita 40
MA - Marocco 38
AU - Australia 35
MU - Mauritius 35
EG - Egitto 34
PY - Paraguay 34
PK - Pakistan 33
CL - Cile 26
EU - Europa 26
PE - Perù 25
IL - Israele 24
AE - Emirati Arabi Uniti 22
KE - Kenya 22
AZ - Azerbaigian 20
DK - Danimarca 17
JM - Giamaica 17
JO - Giordania 17
KR - Corea 17
TN - Tunisia 16
UY - Uruguay 16
CH - Svizzera 15
LT - Lituania 15
OM - Oman 15
TH - Thailandia 15
IR - Iran 14
ET - Etiopia 13
DZ - Algeria 12
NP - Nepal 12
PA - Panama 11
KZ - Kazakistan 10
RO - Romania 10
BG - Bulgaria 9
BO - Bolivia 9
DO - Repubblica Dominicana 9
KG - Kirghizistan 9
AL - Albania 8
BA - Bosnia-Erzegovina 8
GR - Grecia 8
HN - Honduras 8
HU - Ungheria 8
PT - Portogallo 8
SK - Slovacchia (Repubblica Slovacca) 8
LK - Sri Lanka 7
LV - Lettonia 7
TT - Trinidad e Tobago 7
AM - Armenia 6
HR - Croazia 6
MY - Malesia 6
PS - Palestinian Territory 6
SN - Senegal 6
BB - Barbados 5
CR - Costa Rica 5
LB - Libano 5
AO - Angola 4
BY - Bielorussia 4
CU - Cuba 4
NI - Nicaragua 4
NO - Norvegia 4
PH - Filippine 4
EE - Estonia 3
GA - Gabon 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
RS - Serbia 3
SD - Sudan 3
Totale 49.459
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.462
Fairfield 2.431
Singapore 1.984
Jacksonville 1.974
Houston 1.776
Hong Kong 1.733
Ashburn 1.717
Ann Arbor 1.355
Cambridge 1.085
Warsaw 1.066
Wilmington 972
Seattle 949
Princeton 935
Chandler 799
Beijing 790
Nanjing 655
New York 604
Dublin 488
Istanbul 434
Los Angeles 412
Helsinki 342
Munich 334
Des Moines 324
Brescia 285
Ho Chi Minh City 285
Nanchang 265
Dallas 264
São Paulo 239
The Dalles 223
Shanghai 204
Buffalo 196
Moscow 190
Redondo Beach 177
Milan 176
Changsha 171
San Diego 167
Hanoi 165
Shenyang 165
Dearborn 148
San Francisco 139
Jinan 132
Tianjin 130
Hebei 129
Boardman 117
Jiaxing 108
Turku 108
Chicago 98
London 88
Brooklyn 78
Hangzhou 77
Verona 76
Kunming 75
Rio de Janeiro 70
Kocaeli 65
Nuremberg 65
Santa Clara 64
Tokyo 61
Brasília 60
Brno 59
Brussels 56
Zhengzhou 55
Curitiba 53
Belo Horizonte 52
Guangzhou 52
Toronto 52
Johannesburg 51
Pune 51
Atlanta 49
Ningbo 49
Denver 47
Romola 47
Boston 44
Lanzhou 44
Montreal 40
Orem 40
Phoenix 40
Rome 40
Stockholm 39
Tashkent 39
Dong Ket 36
Salvador 34
Norwalk 33
Poplar 33
Haiphong 32
Jakarta 31
Frankfurt am Main 30
Guarulhos 30
Mexico City 30
Taizhou 30
Chennai 29
Campinas 28
Charlotte 27
Haikou 27
Lappeenranta 27
Porto Alegre 27
Baghdad 26
Biên Hòa 26
Goiânia 26
Manchester 26
Orange 26
Totale 32.294
Salva come PNG Salva come JPEG
Nome #
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 292
BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE 272
Postremission sequential monitoring of minimal residual disease by WT1 Q-PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk-adapted therapy in acute myeloid leukemia patients 269
Circulating endothelial cell count: a reliable marker of endothelial damage in patients undergoing hematopoietic stem cell transplantation 258
A standardized flow cytometry network study for the assessment of circulating endothelial cell physiological ranges 241
“Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay.” Is dPCR the key? 231
Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain 225
Effects and outcome of a policy of intermittent imatinib treatment in elderly patients with chronic myeloid leukemia. 225
Zebrafish disease models in hematology: Highlights on biological and translational impact 215
Do chromosomal abnormalities show up during mesenchymal stromal cell expansion? 202
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria 192
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 183
A specific Toll-like receptor profile on T lymphocytes and values of monocytes correlate with bacterial, fungal, and cytomegalovirus infections in the early period of allogeneic stem cell transplantation 181
3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiation 177
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 174
EXPRESSION OF TOLL-LIKE RECEPTORS ON PERIPHERAL BLOOD CELLS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: ONGOING RESULTS OF A PROSPECTIVE STUDY. 173
Targeting HRASV12G Expression to the Zebrafish Early Hemogenic Progenitors Induces a Myeloproliferative Disorder by Repressing the Notch Pathway. 173
Profile of Toll-Like Receptors on Peripheral Blood Cells in Relation to Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation 168
Rational Design and Development of Anisotropic and Mechanically Strong Gelatin-Based Stress Relaxing Hydrogels for Osteogenic/Chondrogenic Differentiation 167
Counting circulating endothelial cells in allo-HSCT: an ad hoc designed polychromatic flowcytometry-based panel versus the CellSearch System 165
Betaherpesvirus Reactivation and Toll-Like Receptor Expression After Allogeneic Stem Cell Transplantation. 164
SIRPB1 Is a Strong Predictor Biomarker of Response to 5-Azacitidine Therapy in MDS and AML Patients 157
TARGETING HRASV12G EXPRESSION TO THE ZEBRAFISH EARLY HEMOGENIC PROGENITORS INDUCES A MYELOPROLIFERATIVE DISORDER BY REPRESSING THE NOTCH PATHWAY. 156
Clinical Care of Hematological Patients in a Bone Marrow Transplant Unit: Do Human Resources Influence Infection Incidence? 156
Central Venous Catheter-Related Bloodstream Infection Caused by Brevibacterium casei in a Hematology Patient 154
Expression of Toll-Like Receptors on Peripheral Blood Cells After Allogeneic Stem Cell Transplantation: Results of a Prospective Study. 152
Fungemia in hematological malignancies: SEIFEM-2015 survey 152
Procoagulant cellular activity and disseminated intravascular coagulation in acute non-lymphoid leukaemia. 151
Acute graft-versus-host disease and expression of Toll-like receptors on peripheral blood cells after allogeneic stem cell transplantation 151
Comparative Somatic Mutational Profiling of CD34+ Hematopoietic Precursors (HSC) and Circulating Endothelial Cells (CEC) in Patients with Primary Myelofibrosis (PMF) 151
A Gene Panel NGS-Based Strategy for Genomic Characterization of Acute Myeloid Leukemias (AMLs) 148
A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patients. 147
Intermittent Imatinib (INTERIM) Treatment of Patients with Ph+ Chronic Myeloid Leukemia in Complete Cytogenetic Response: Cytogenetic and Molecular Data At One Year. 147
Multidimensional Geriatric Assessment for Elderly Patients (≥60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients 145
P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells. 144
Screening of Bcr-Abl transcripts in Philadelphia negative essential thrombocythemia. 143
A prospective comparison of alpha-IFN and conventional chemotherapy in Ph+ chronic myeloid leukemia. Clinical and cytogenetic results at 2 years in 322 patients 142
Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation 142
MULTI-GENOTYPING OF MINOR HISTOCOMPATIBILITY ANTIGENS (MHAGS) IN ALLOGENEIC STEM CELL TRANSPLANTATION AND THEIR ROLE IN DETERMINING GRAFT VERSUS HOST DISEASE (GVHD) AND GRAFT VERSUS LEUKEMIA (GVL) EFFECT. 141
Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR) 140
Development of BCR-ABL1 Transgenic Zebrafish Model Reproducing Chronic Myeloid Leukemia (CML) Like-Disease and Providing a New Insight into CML Mechanisms 140
Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target? 139
Antilymphocyte globulin for prevention of chronic graft-versus-host disease 139
Central nervous system angiitis in Hodgkin's disease. 138
Advances in CMV Management: A Single Center Real-Life Experience 138
PARAMETERS OF PROTEIN METABOLISM AND THYROID FUNCTION AS PREDICTORS OF A SCORING SYSTEM FOR ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE 137
Baseline factors associated with response to ruxolitinib: An independent study on 408 patients with myelofibrosis 137
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS 137
Development of a cell culture model based on biocompatible polymeric scaffolds engineered with human Mesenchymal Stromal Cells (MSCs) for cartilage and bone regenerative therapy 137
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review 134
Assessment of Liver Damage with Transient Hepatic Elastography (FIBROSCAN) in patients with chronic Graft-Versus-Host Disease. 134
Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse 134
Targeting oncogene expression to endothelial cells induces proliferation of the myelo-erythroid lineage by repressing the notch pathway. 134
First Interim Report of the Italian Multicentric Phase-III Randomized Study to Optimize TKIs Multiple Approaches - (OPTkIMA) in Elderly Patients (older than 60 years) with Ph+ Chronic Myeloid Leukemia (CML) and MR3.0/ MR4.0 Stable Molecular Response 134
Chitosan-Hydrogel Polymeric Scaffold Acts as an Independent Primary Inducer of Osteogenic Differentiation in Human Mesenchymal Stromal Cells 134
Procoagulant cellular activity and disseminated intravascular coagulation in acute non-lymphoid leukaemia 133
5-azacitidine five days/monthly schedule in symptomatic low-risk (IPSS: 0-1) myelodisplastic (MDS) patients. clinical and biological effects. 133
Laboratory diagnostics of inherited platelet disorders. 133
"Real-life' analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 study 133
Single Cell Analysis of Circulating Endothelial Cells in Allogeneic Hematopoietic Stem Cell Transplant; To Whom Do They Belong: Host or Donor? 133
Sensitivity of chronic myeloid leukemia hemopoietic progenitors to PTT-119 in combination with human recombinant interferon alpha and gamma 131
Overexpression of multidrug resistance-associated p170-glycoprotein in acute non-lymphocytic leukemia 130
Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP) 129
Use of a high sensitive nanofluidic array for the detection of rare copies of BCR-ABL1 transcript in patients with Philadelphia-positive acute lymphoblastic leukemia in complete response. 129
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients? 129
Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-kit positive acute myeloid leukemia. Results of an italian multicentric phase II study. 128
Laparoscopic splenectomy in the management of hematological diseases 127
A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patients. 127
Parameters of Protein Metabolism and Thyroid Function As Predictors in a Scoring System for Acute and Chronic Graft-Versus-Host Disease 127
Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment 127
Long-term follow-up of the Italian trial of interferon- versus conventional chemotherapy in chronic myeloid leukemia 126
Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia 126
Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach 126
A first update on mapping the human genetic architecture of COVID-19 125
SHP-1 expression accounts for resistance to imatinib treatment in Philadelphia chromosome-positive cells derived from patients with chronic myeloid leukemia. 125
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: An open-label, multicentre, randomised, phase 3 trial 125
Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing 125
Clinical impact of low-burden BCR-ABL1 mutations detectable by amplicon deep sequencing in Philadelphia-positive acute lymphoblastic leukemia patients 125
The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype. 124
Rituximab in a case of cold agglutinin disease 124
Advances in the treatment of monoclonal gammapathies: the emerging role of targeted therapy in plasma cell dyscrasias. 124
Bioengineered scaffolding for mandibular reconstruction: a preclinical, xenograft animal study 124
Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases 123
Does the type of BCR/ABL junction predict the survival of patients with Ph1-positive chronic myeloid leukemia? 123
Index of Bone Marrow Output and Imbalance of B-Lymphocyte Homeostasis before and after Transplantation Correlate Differently with Graft-Versus-Host Disease and Relapse 123
Impedance-based monitoring of mesenchymal stromal cell three-dimensional proliferation using aerosol jet printed sensors: A tissue engineering application 123
Quantitative evaluation of BCR-ABL amount of transcript post mobilization with G-CSF of peripheral blood stem cells from chronic myeloid leukemia patients in cytogenetic response. 122
Treatment of Ph+ chronic myeloid leukemia by gamma interferon 122
Peripheral Blood WT1 Expression Predicts Relapse in AML Patients Undergoing Allogeneic Stem Cell Transplantation. 122
Lenalidomide treatment of myelodysplastic syndromes with chromosome 5q deletion: Results from the National Registry of the Italian Drug Agency 122
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease 122
INTEGRATED CORE-SHELL BIOACTIVE STRUCTURE FOR THE REGENERATION OF BONE AND OSTEOCHONDRAL TISSUES 122
3D-MAPPING OF MESENCHYMAL STEM CELLS GROWTH ON BIOENGINEERED SCAFFOLDS FOR MAXILLOFACIAL SKELETON REGENERATION: A PRECLINICAL, IN VITRO STUDY 122
Case-control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients. 121
Expression of Toll-like receptors on peripheral blood cells after allogeneic stem cell transplantation: ongoing results of a prospective study. 121
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations 121
CT-290: Clinical Frailty Scale as a Novel Tool to Evaluate Patients’ Eligibility for Allogeneic Stem Cell Transplant: A Single-Center Experience on 234 Patients >50 Years Old 121
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia – analysis of 848 patients. 120
A multicenter double-bind placebo-controlled trial comparing piperacillin tazobactam with and without amikacin as empiric therapy for febrile neutropenia 120
Fludarabine in patients with advanced and/or resistant B-chronic lymphocytic leukemia 120
Totale 14.850
Salva come PNG Salva come JPEG
Categoria #
all - tutte 262.690
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 262.690
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.152 0 0 0 0 0 784 272 736 808 702 597 253
2021/20223.524 201 575 66 244 107 233 171 266 198 441 274 748
2022/20232.713 571 96 68 211 213 725 13 229 318 35 105 129
2023/20243.469 162 75 233 168 151 598 159 140 953 41 64 725
2024/20258.648 76 93 95 972 922 700 731 274 1.097 685 1.684 1.319
2025/202610.395 1.558 2.529 1.591 2.962 1.579 176 0 0 0 0 0 0
Totale 50.564